Trump lost control and ordered me to be ‘quiet’ in the Oval Office. Then it got personal - FIRST PERSON: What was supposed to ...

TORONTO, ON / ACCESS Newswire / October 21, 2026 / (TSX:ADCO)(OTCQX:ADCOF)(FSE:ADQ) ("Adcore" or the "Company"), the ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage biotechnology company developing gene therapies ...

Gordon says his years of experience fighting criminal charges will serve him well as attorney general.

New Cellgorithm™ data presented at ISSCR symposium indicates faster, scalable cell programming and add to Syntax Bio’s ...

Smart TVs were designed to make entertainment more convenient, but their increasingly complicated interfaces, built-in ...

Meta has temporarily suspended the conversation sharing feature in its Muse AI after researchers discovered that public links ...

EVERGREEN Phase 3 Trial-in-Progress poster presents planned study design of JADE101 in IgA nephropathy; initiation now expected in the fourth quarter of 2026JUNIPER Phase 2 Trial-in-Progress poster ...

Audience measurement is moving beyond traditional ratings and viewership totals as broadcasters and streaming platforms ...

FDA clearance enables clinical development of OPGx-RDH12 for RDH12-associated Leber congenital amaurosis, a rare inherited retinal disease that causes progressive vision loss beginning in early childh ...

Netflix has cut its 2026 advertising forecast to $2.7 billion as weaker fourth-quarter guidance adds pressure following job cuts and leadership changes.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Commission (EC) has approved KEYTRUDA ® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination ...